RUNX2 and pulmonary arterial hypertension: Interestingly, RUNX2 is found to be upregulated in the lungs, distal pulmonary arteries, and primary cultured human pulmonary ASMCs isolated from PAH patients and plays a pivotal role in the pathogenesis or the development of proliferative and calcified pulmonary artery lesions [63].